For generations, millions of women have been told they have Polycystic Ovary Syndrome, or PCOS: a name that sounds almost quaint, conjuring images of mysterious cysts tucked inside the ovaries. But the reality has always been far more complex, and far more whole-body, than that label suggested for a century. Now, after decades of advocacy and evolving science, experts are giving the condition a fresh identity: PMOS, or PolyMetabolic Ovary Syndrome (sometimes described as Polyendocrine Metabolic Ovarian Syndrome). This is more than a cosmetic tweak. It is a fundamental shift in how we understand one of the most common medical conditions affecting women of reproductive age, one that continues to ripple through their health long after childbearing years.
The Problem with Just 'Cysts'
The story begins in 1935, when two American doctors noticed enlarged ovaries dotted with small sacs in women struggling with irregular periods and infertility. They called it polycystic ovary syndrome, and the name stuck. The trouble is, those cysts are not true cysts at all. They are immature egg follicles whose development has stalled because of deeper hormonal chaos. Many women with the condition do not even have them visible on scans. Yet the old name kept the conversation narrowly focused on ovaries and reproduction for a century. It led patients and doctors alike to believe this was primarily a fertility or women's troubles issue. While PMOS can lead to irregular menstrual periods, abnormal ovulation, excess facial or body hair, acne, and sometimes infertility, it is also associated with significant endocrine, metabolic, psychological, and dermatological symptoms. These can persist far beyond a person's reproductive years.
Why the Name Change Matters
The previous name, PCOS, reflected only one organ and failed to capture the disorder's multisystem nature. This is a travesty considering PMOS impacts roughly 170 million women worldwide, with up to 70 percent of patients going undiagnosed. Dr. David Chandy, director of endocrinology at Sir HN Reliance Hospital, says the transition to PMOS is a clinical milestone that refines our long-standing understanding of women's health. For too long, the term 'polycystic' suggested that ovarian cysts were the primary issue, yet many patients never develop them. By incorporating 'polyendocrine' and 'metabolic' into the name, we are finally aligning terminology with the root cause: a complex hormonal and insulin imbalance. This shift helps strip away the stigma of cysts and empowers patients to see that lifestyle management is not just a secondary recommendation but the primary treatment for what is truly a systemic endocrine disorder.
Dr. Muskaan Chhabra, fertility specialist at Birla Fertility & IVF, New Delhi, says the renaming is a clinically significant development that those working in reproductive medicine have welcomed as a necessary evolution. Many patients in India were told they had PCOS for decades, and even this term was myopic in scope, remaining an informal ovary-focused description that did not capture the hormonal and metabolic complexity underlying the condition.
What Exactly Is PMOS?
PMOS is a multisystem condition driven by insulin resistance, hormonal imbalance, chronic low-grade inflammation, and genetic factors. It touches metabolism, heart health, skin, mood, and energy levels. Dr. Helena Teede, an Australian endocrinologist who has led the renaming effort, puts it plainly: the ovaries are involved, but they are not the origin story. The disruption often runs deeper, possibly even beginning in the brain's signaling pathways.
Dr. Manisha Arora, director of internal medicine at CK Birla Hospital, Delhi, says the previous name did not describe the condition accurately because many women think they do not have PCOS if they do not have visible cysts on an ultrasound. In reality, women who have hormonal and metabolic problems often have normal-looking ovaries on an ultrasound. This has led to late or missed diagnoses. The new name, PMOS, will help women understand that what they have is not just an ovarian problem but a complicated endocrine and metabolic problem affecting insulin, testosterone, cortisol, and many different systems of the body. This creates more awareness, clears up confusion, and encourages women to seek medical help sooner.
Dr. Satish Koul, principal director and unit head of internal medicine at FMRI, says renaming PCOS as PMOS is an important shift because the condition is far more than an ovarian disorder. Not every woman with polycystic ovaries has PCOS, and not every woman with PCOS actually has polycystic ovaries. The older term failed to capture the broader hormonal and metabolic nature of the condition. PMOS better reflects the endocrine and metabolic complications linked to the disorder, especially insulin resistance. Patients can experience ovarian issues, hormonal imbalance, metabolic dysfunction, and even mental-health challenges, which is why treatment now requires a multidisciplinary approach, not just gynecological care. The condition evolves across a woman's life: in adolescence, symptoms may include acne or facial hair; in their 20s, women may struggle with conception; and by their 30s, many are at risk of diabetes because PMOS is strongly linked to insulin resistance.
What It Actually Feels Like
If you have PMOS, the symptoms can feel like a scattered puzzle: irregular or absent periods, acne that lingers into adulthood, unwanted facial or body hair, thinning hair on the scalp, difficulty conceiving, stubborn weight gain especially around the middle, crushing fatigue, anxiety or low mood. Behind the scenes, insulin resistance raises the long-term risk of Type 2 diabetes, fatty liver, high blood pressure, sleep apnea, and cardiovascular disease. Many women attribute these symptoms to hormones and let them go, but they may indicate PMOS.
Dr. Anuranjita Pallavi, senior consultant gynecologist and fertility & IVF specialist at Motherhood Fertility & IVF, Navi Mumbai, says many women who remained undiagnosed will now get diagnosed. Many women with PMOS report medical gaslighting because symptoms of hormonal imbalance, insulin resistance, and weight gain are often dismissed or labeled as emotional issues. Sometimes these symptoms are mistaken for stress, poor diet, or disrupted mental well-being, taking a huge toll on women's health. She urges women to look for signs such as irregular periods, excessive facial and body hair, acne, and sudden weight gain, as they are all indications of PMOS.
Treatment: Moving Beyond the Pill
The renaming has opened the door to smarter, more comprehensive care. Instead of defaulting to hormonal contraceptives for symptom control, clinicians are increasingly looking at the metabolic roots. Lifestyle remains foundational: regular movement (especially strength training and brisk walking), quality sleep, stress management, and a diet that stabilizes blood sugar are all needed. These changes can dramatically improve insulin sensitivity, hormone balance, and overall well-being, even in women who do not lose much weight. Newer options like GLP-1 medications (the class behind drugs such as semaglutide) are showing promise for tackling insulin resistance and supporting sustainable weight management. Multidisciplinary teams including endocrinologists, nutritionists, dermatologists, psychologists, and trainers are becoming the gold standard. Mental health support is no longer an afterthought; addressing anxiety, depression, and body image is now seen as core treatment of PMOS.
A Wider Cultural Shift
The move from PCOS to PMOS mirrors a larger evolution in women's health. For too long, female hormonal issues were siloed in gynecology and reduced to reproduction. Today we understand hormones influence everything from heart disease risk to brain health, immunity, and how we age. Dr. Bushra Khan, fertility specialist at Nova IVF Fertility, Kharadi, Pune, points out that the traditional name led to confusion, with many patients focusing solely on ovarian cysts, although the condition is mainly driven by hormonal imbalance and insulin resistance. Some women display polycystic ovarian morphology through ultrasound testing yet do not possess the actual condition, creating difficulties in diagnosis and counseling.
From 1935 to the end of the 1970s, research was mostly focused on the hormonal aspects of PCOS. In the last two decades of the 20th century, the focus shifted to metabolic issues involving hormones such as insulin. In a world of ultra-processed food, chronic stress, and disrupted sleep, metabolic and hormonal disorders are rising across the board. Reframing PMOS as a metabolic-endocrine condition helps destigmatize it, attract better research funding, and push for earlier screening, especially in high-risk groups like those with family histories of diabetes.
Dr. Santosh Bangar, senior consultant psychiatrist at Gleneagles Hospital, Mumbai, talks about the future possibility of a positive impact on mental well-being due to this holistic approach. PMOS is a common but complex condition. Delayed diagnosis or dismissal leaves women frustrated and exhausted because no one listens or understands them. The missed periods, facial and body hair, acne, and insulin resistance can all affect relationships, fertility, and confidence, causing more anxiety and self-doubt, which eventually leads to depression. The new name acknowledges PMOS as a multisystem endocrine and metabolic disorder, in which the ovaries are just one of several systems involved rather than the primary site of the problem. For patients who have received any of these diagnoses, what matters most is that this progression in nomenclature reflects a growing commitment to seeing and treating the person holistically.
The Road Ahead
The new name, PMOS, will roll out gradually. By 2028, it should appear in the International Classification of Diseases, standardizing records and research worldwide. Some pushback is expected from brands and influencers heavily invested in PCOS awareness, but the women living with the condition have made their preference clear. For patients, this rebrand is quietly revolutionary. It replaces confusion and shame with clarity and legitimacy. It tells a woman struggling with stubborn weight, relentless acne, and crushing periods that her body is not broken in some mysterious ovarian way; it is dealing with a recognizable, manageable metabolic-hormonal pattern that modern medicine is finally learning to address holistically.
If you suspect you might have PMOS, do not wait for perfect cysts on a scan. Track your cycles, note symptoms, and seek a doctor to test androgens, insulin markers, and AMH. The right name will not magically cure anything, but it can be the first step toward truly being heard, properly screened, and effectively treated. Because women's health is not just about ovaries. It is about whole, vibrant lives, and medicine is finally catching up after a long, hard struggle by women worldwide.
